nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—malignant glioma	0.907	1	CbGaD
Ximelagatran—F2—vertebral column—malignant glioma	0.0115	0.455	CbGeAlD
Ximelagatran—F2—endothelium—malignant glioma	0.00511	0.202	CbGeAlD
Ximelagatran—F2—blood vessel—malignant glioma	0.00471	0.187	CbGeAlD
Ximelagatran—F2—spinal cord—malignant glioma	0.0016	0.0635	CbGeAlD
Ximelagatran—F2—central nervous system—malignant glioma	0.0013	0.0515	CbGeAlD
Ximelagatran—F2—brain—malignant glioma	0.00103	0.0409	CbGeAlD
Ximelagatran—F2—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.000286	0.00422	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—FN1—malignant glioma	0.000283	0.00418	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.000282	0.00417	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000279	0.00411	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PTK2—malignant glioma	0.00027	0.00398	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PTPN11—malignant glioma	0.000266	0.00393	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—malignant glioma	0.000265	0.00391	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—malignant glioma	0.000264	0.0039	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—KNG1—malignant glioma	0.000264	0.00389	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00026	0.00384	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.000259	0.00382	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PDGFRA—malignant glioma	0.000252	0.00372	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—PIK3CA—malignant glioma	0.000247	0.00364	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—malignant glioma	0.00024	0.00354	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—malignant glioma	0.000236	0.00349	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IFNG—malignant glioma	0.000236	0.00348	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.000236	0.00348	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000231	0.0034	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—AKT1—malignant glioma	0.000227	0.00336	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PDGFB—malignant glioma	0.000226	0.00334	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000226	0.00334	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—FGFR1—malignant glioma	0.000225	0.00333	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—malignant glioma	0.000219	0.00323	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ANGPT2—malignant glioma	0.000216	0.00318	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR4—malignant glioma	0.000215	0.00317	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000214	0.00316	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000211	0.00312	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—malignant glioma	0.00021	0.00311	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00021	0.0031	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.000209	0.00308	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—XBP1—malignant glioma	0.000208	0.00307	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CB—malignant glioma	0.000208	0.00307	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—FN1—malignant glioma	0.000204	0.00302	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.0002	0.00295	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000198	0.00292	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000197	0.0029	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CG—malignant glioma	0.000195	0.00289	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—APC—malignant glioma	0.000195	0.00289	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGF—malignant glioma	0.000193	0.00285	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—malignant glioma	0.000192	0.00284	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000192	0.00283	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HIST1H3B—malignant glioma	0.000187	0.00276	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MYB—malignant glioma	0.000185	0.00273	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—BRAF—malignant glioma	0.000184	0.00271	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LATS2—malignant glioma	0.000184	0.00271	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—malignant glioma	0.000179	0.00264	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000175	0.00258	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CD—malignant glioma	0.000172	0.00254	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000171	0.00252	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—malignant glioma	0.000169	0.0025	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000168	0.00248	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000165	0.00244	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—FGF2—malignant glioma	0.000165	0.00243	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCR3—malignant glioma	0.00016	0.00236	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—SPHK1—malignant glioma	0.000154	0.00228	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—RAF1—malignant glioma	0.000153	0.00226	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—malignant glioma	0.000153	0.00225	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CB—malignant glioma	0.00015	0.00221	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000149	0.0022	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000148	0.00218	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—BDKRB2—malignant glioma	0.000146	0.00216	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000146	0.00215	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—H3F3A—malignant glioma	0.000144	0.00213	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000143	0.00211	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000143	0.00211	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000141	0.00208	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LATS1—malignant glioma	0.000139	0.00205	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—KRAS—malignant glioma	0.000138	0.00203	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—KNG1—malignant glioma	0.000133	0.00196	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.00013	0.00193	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CA—malignant glioma	0.000127	0.00187	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000125	0.00185	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR4—malignant glioma	0.000121	0.00179	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.00012	0.00177	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KNG1—malignant glioma	0.000119	0.00175	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.000119	0.00175	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA2—malignant glioma	0.000116	0.00172	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000115	0.0017	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000114	0.00169	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000112	0.00166	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000112	0.00165	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SOD1—malignant glioma	0.00011	0.00163	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR4—malignant glioma	0.00011	0.00163	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000109	0.00161	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—BCHE—malignant glioma	0.000107	0.00157	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGFR—malignant glioma	0.000105	0.00155	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—FBXW7—malignant glioma	0.000105	0.00155	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PTK2—malignant glioma	0.000101	0.0015	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.0001	0.00148	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—malignant glioma	9.94e-05	0.00147	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MDK—malignant glioma	9.4e-05	0.00139	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	9.13e-05	0.00135	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCR3—malignant glioma	9.03e-05	0.00133	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DTX1—malignant glioma	8.97e-05	0.00132	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	8.53e-05	0.00126	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PDGFB—malignant glioma	8.52e-05	0.00126	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RTEL1—malignant glioma	8.39e-05	0.00124	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—malignant glioma	8.3e-05	0.00122	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—BDKRB2—malignant glioma	8.26e-05	0.00122	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCR3—malignant glioma	8.2e-05	0.00121	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	8.18e-05	0.00121	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CAV1—malignant glioma	8.07e-05	0.00119	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	7.95e-05	0.00117	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	7.85e-05	0.00116	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—FN1—malignant glioma	7.68e-05	0.00113	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PIK3CA—malignant glioma	7.61e-05	0.00112	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—KNG1—malignant glioma	7.51e-05	0.00111	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—BDKRB2—malignant glioma	7.5e-05	0.00111	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	7.41e-05	0.00109	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CG—malignant glioma	7.35e-05	0.00109	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—EGF—malignant glioma	7.27e-05	0.00107	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PTPN11—malignant glioma	7.22e-05	0.00107	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SUFU—malignant glioma	7.12e-05	0.00105	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HEY2—malignant glioma	7.04e-05	0.00104	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GFAP—malignant glioma	6.87e-05	0.00101	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KNG1—malignant glioma	6.82e-05	0.00101	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	6.81e-05	0.00101	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT2—malignant glioma	6.73e-05	0.000993	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	6.66e-05	0.000983	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SPHK1—malignant glioma	6.65e-05	0.000982	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HEY1—malignant glioma	6.52e-05	0.000962	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR4—malignant glioma	6.52e-05	0.000962	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CD—malignant glioma	6.46e-05	0.000954	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIST1H3B—malignant glioma	6.33e-05	0.000934	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—malignant glioma	6.05e-05	0.000894	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MMP3—malignant glioma	6.04e-05	0.000892	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.99e-05	0.000885	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.8e-05	0.000856	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAG2—malignant glioma	5.78e-05	0.000853	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAF1—malignant glioma	5.77e-05	0.000852	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CB—malignant glioma	5.63e-05	0.000831	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—malignant glioma	5.44e-05	0.000803	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—malignant glioma	5.17e-05	0.000764	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—malignant glioma	5.12e-05	0.000756	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—H3F3A—malignant glioma	4.89e-05	0.000722	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCR3—malignant glioma	4.84e-05	0.000715	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COX8A—malignant glioma	4.82e-05	0.000711	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK2—malignant glioma	4.71e-05	0.000695	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—YWHAE—malignant glioma	4.71e-05	0.000695	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FLT1—malignant glioma	4.69e-05	0.000692	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DUSP6—malignant glioma	4.67e-05	0.000689	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—malignant glioma	4.65e-05	0.000686	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAG1—malignant glioma	4.61e-05	0.00068	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH3—malignant glioma	4.59e-05	0.000678	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FBXW7—malignant glioma	4.52e-05	0.000667	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BDKRB2—malignant glioma	4.43e-05	0.000654	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—malignant glioma	4.4e-05	0.000649	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.31e-05	0.000636	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—malignant glioma	4.26e-05	0.000629	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT2—malignant glioma	4.25e-05	0.000627	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—malignant glioma	4.22e-05	0.000623	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTPN11—malignant glioma	4.14e-05	0.000612	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH2—malignant glioma	4.12e-05	0.000608	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ASMT—malignant glioma	4.1e-05	0.000605	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CD—malignant glioma	4.08e-05	0.000603	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KNG1—malignant glioma	4.03e-05	0.000595	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4e-05	0.000591	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT2—malignant glioma	3.86e-05	0.00057	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BCAN—malignant glioma	3.85e-05	0.000568	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK1—malignant glioma	3.84e-05	0.000567	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—malignant glioma	3.74e-05	0.000552	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CD—malignant glioma	3.71e-05	0.000547	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP3—malignant glioma	3.57e-05	0.000527	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CB—malignant glioma	3.56e-05	0.000525	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN2B—malignant glioma	3.54e-05	0.000522	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTK2—malignant glioma	3.44e-05	0.000507	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—malignant glioma	3.43e-05	0.000507	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—malignant glioma	3.42e-05	0.000505	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HES1—malignant glioma	3.38e-05	0.000498	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NCOR1—malignant glioma	3.36e-05	0.000495	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—malignant glioma	3.32e-05	0.00049	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RAF1—malignant glioma	3.31e-05	0.000489	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—malignant glioma	3.27e-05	0.000483	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CB—malignant glioma	3.23e-05	0.000477	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDGFRA—malignant glioma	3.21e-05	0.000474	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SPP1—malignant glioma	3.12e-05	0.000461	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—malignant glioma	3.11e-05	0.000459	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—IDH2—malignant glioma	3.1e-05	0.000458	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—malignant glioma	2.97e-05	0.000438	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—malignant glioma	2.96e-05	0.000437	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.93e-05	0.000432	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.92e-05	0.000431	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDGFB—malignant glioma	2.89e-05	0.000426	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGFR1—malignant glioma	2.87e-05	0.000424	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIF1A—malignant glioma	2.83e-05	0.000418	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—malignant glioma	2.81e-05	0.000414	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CAV1—malignant glioma	2.74e-05	0.000404	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—malignant glioma	2.71e-05	0.000399	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—IDH1—malignant glioma	2.67e-05	0.000394	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FN1—malignant glioma	2.6e-05	0.000384	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SPHK1—malignant glioma	2.58e-05	0.000381	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BAD—malignant glioma	2.57e-05	0.00038	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH1—malignant glioma	2.55e-05	0.000376	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.53e-05	0.000374	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CD80—malignant glioma	2.5e-05	0.000369	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APC—malignant glioma	2.49e-05	0.000368	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—malignant glioma	2.49e-05	0.000368	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGF—malignant glioma	2.46e-05	0.000364	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTPN11—malignant glioma	2.45e-05	0.000361	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.39e-05	0.000352	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BRAF—malignant glioma	2.34e-05	0.000346	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT2—malignant glioma	2.28e-05	0.000337	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—malignant glioma	2.27e-05	0.000335	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CD—malignant glioma	2.19e-05	0.000323	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.17e-05	0.000321	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—malignant glioma	2.17e-05	0.00032	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—malignant glioma	2.14e-05	0.000317	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.1e-05	0.00031	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF2—malignant glioma	2.1e-05	0.00031	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—malignant glioma	2.05e-05	0.000302	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—malignant glioma	1.97e-05	0.000291	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MDM2—malignant glioma	1.96e-05	0.00029	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RAF1—malignant glioma	1.96e-05	0.000289	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB2—malignant glioma	1.94e-05	0.000286	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS1—malignant glioma	1.92e-05	0.000283	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.91e-05	0.000282	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CB—malignant glioma	1.91e-05	0.000282	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—malignant glioma	1.84e-05	0.000271	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BCHE—malignant glioma	1.78e-05	0.000263	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—malignant glioma	1.77e-05	0.000262	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.76e-05	0.00026	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—malignant glioma	1.76e-05	0.000259	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—malignant glioma	1.75e-05	0.000259	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.67e-05	0.000246	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—malignant glioma	1.66e-05	0.000245	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.65e-05	0.000244	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—malignant glioma	1.65e-05	0.000244	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—malignant glioma	1.61e-05	0.000238	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—malignant glioma	1.49e-05	0.00022	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—malignant glioma	1.48e-05	0.000218	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.44e-05	0.000212	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—malignant glioma	1.42e-05	0.000209	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAT—malignant glioma	1.38e-05	0.000204	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—malignant glioma	1.37e-05	0.000202	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—malignant glioma	1.34e-05	0.000198	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOR1—malignant glioma	1.3e-05	0.000192	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—malignant glioma	1.27e-05	0.000187	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—malignant glioma	1.16e-05	0.000172	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—malignant glioma	1.13e-05	0.000166	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAV1—malignant glioma	1.06e-05	0.000157	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.02e-05	0.00015	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—malignant glioma	9.68e-06	0.000143	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—malignant glioma	9.51e-06	0.00014	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—malignant glioma	9.34e-06	0.000138	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CD—malignant glioma	8.51e-06	0.000126	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CB—malignant glioma	7.42e-06	0.000109	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—malignant glioma	7.35e-06	0.000108	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—malignant glioma	6.41e-06	9.46e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.52e-06	6.67e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—malignant glioma	3.69e-06	5.45e-05	CbGpPWpGaD
